Market Overview

NJ Woman Sues Novartis over Pricing of Similar Excedrin Pain Medicines

Share:
NJ Woman Sues Novartis over Pricing of Similar Excedrin Pain Medicines
Related NVS
What If Trump Keeps Badmouthing Drug Pricing?
8 Of The Biggest Biotech Announcements Out Of The 2016 ASH Meeting
Cancer Immunotherapy Market: 2016 Takeaways And What To Expect In 2017 (Seeking Alpha)

A Cherry Hill, NJ woman has filed a lawsuit against Novartis (NYSE: NVS), accusing the company of selling its Excedrin Migraine medicine for higher price than Excedrin Extra Strength, though both medications have identical ingredients in identical quantities. According to View The Star Ledger, Excedrin Migraine costs about 12-15 percent more than Excedrin Extra Strength.

Posted-In: News Legal

 

Related Articles (NVS)

View Comments and Join the Discussion!